TGM2 and celiac disease: Thus, patients with a clinical suspicion for IPH should be screened promptly for celiac disease with serologic testing, such as tissue transglutaminase IgA and endomysial antibodies, even in the absence of gastrointestinal symptoms [1, 2, 4–8].